Fatty acid transport protein 2 reprograms neutrophils in cancer

Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite recent advances...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2019-05, Vol.569 (7754), p.73-78
Hauptverfasser: Veglia, Filippo, Tyurin, Vladimir A., Blasi, Maria, De Leo, Alessandra, Kossenkov, Andrew V., Donthireddy, Laxminarasimha, To, Tsun Ki Jerrick, Schug, Zach, Basu, Subhasree, Wang, Fang, Ricciotti, Emanuela, DiRusso, Concetta, Murphy, Maureen E., Vonderheide, Robert H., Lieberman, Paul M., Mulligan, Charles, Nam, Brian, Hockstein, Neil, Masters, Gregory, Guarino, Michael, Lin, Cindy, Nefedova, Yulia, Black, Paul, Kagan, Valerian E., Gabrilovich, Dmitry I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 78
container_issue 7754
container_start_page 73
container_title Nature (London)
container_volume 569
creator Veglia, Filippo
Tyurin, Vladimir A.
Blasi, Maria
De Leo, Alessandra
Kossenkov, Andrew V.
Donthireddy, Laxminarasimha
To, Tsun Ki Jerrick
Schug, Zach
Basu, Subhasree
Wang, Fang
Ricciotti, Emanuela
DiRusso, Concetta
Murphy, Maureen E.
Vonderheide, Robert H.
Lieberman, Paul M.
Mulligan, Charles
Nam, Brian
Hockstein, Neil
Masters, Gregory
Guarino, Michael
Lin, Cindy
Nefedova, Yulia
Black, Paul
Kagan, Valerian E.
Gabrilovich, Dmitry I.
description Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite recent advances in the understanding of PMN-MDSC biology, the mechanisms responsible for the pathological activation of neutrophils are not well defined, and this limits the selective targeting of these cells. Here we report that mouse and human PMN-MDSCs exclusively upregulate fatty acid transport protein 2 (FATP2). Overexpression of FATP2 in PMN-MDSCs was controlled by granulocyte–macrophage colony-stimulating factor, through the activation of the STAT5 transcription factor. Deletion of FATP2 abrogated the suppressive activity of PMN-MDSCs. The main mechanism of FATP2-mediated suppressive activity involved the uptake of arachidonic acid and the synthesis of prostaglandin E 2 . The selective pharmacological inhibition of FATP2 abrogated the activity of PMN-MDSCs and substantially delayed tumour progression. In combination with checkpoint inhibitors, FATP2 inhibition blocked tumour progression in mice. Thus, FATP2 mediates the acquisition of immunosuppressive activity by PMN-MDSCs and represents a target to inhibit the functions of PMN-MDSCs selectively and to improve the efficiency of cancer therapy. The lipid transporter FATP2 reprograms neutrophils to polymorphonuclear myeloid-derived suppressor cells by mediating the uptake of arachidonic acid and promoting the synthesis of prostaglandin E 2 .
doi_str_mv 10.1038/s41586-019-1118-2
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2224909285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A584125872</galeid><sourcerecordid>A584125872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c720t-592c84f846faf17b7fefde5434b5e130097e6b626be5d5ac4eba5e961f3538293</originalsourceid><addsrcrecordid>eNp10tFq1TAYB_AgijtOH8AbKXo1pDNJkzS983DYdDA20ImXIU2_1IzTtEtS2N5mz-KTmcOZzgNn5CKk-X1fk_aP0FuCjwmu5KfICJeixKQpCSGypM_QgrBalEzI-jlaYExliWUlDtCrGK8xxpzU7CU6qHDTiIqJBfp8qlO6K7RxXZGC9nEaQyqmMCZw_vc9LQLkRR_0EAsPcwrj9MutY-F8YbQ3EF6jF1avI7x5mA_Rj9OTq9XX8vzyy9lqeV6amuJU8oYayaxkwmpL6ra2YDvgrGItB1Jh3NQgWkFFC7zj2jBoNYdGEFvxStKmOkQftn3zcW5miEldj3Pw-ZWKUsoa3FDJH1Wv16Cct2O-lBlcNGrJJSOUy5pmVe5RPXgIej16sC4_3vHv93gzuRv1Pzreg_LoYHBmb9ejnYJsEtymXs8xqrPv33btx6ft8urn6mJXk602YYwxgFVTcIMOd4pgtUmO2iZH5eSoTXLUpubdw_ed2wG6fxV_o5IB3YKYt3wP4fEHPN31D3EmyXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2224909285</pqid></control><display><type>article</type><title>Fatty acid transport protein 2 reprograms neutrophils in cancer</title><source>MEDLINE</source><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Veglia, Filippo ; Tyurin, Vladimir A. ; Blasi, Maria ; De Leo, Alessandra ; Kossenkov, Andrew V. ; Donthireddy, Laxminarasimha ; To, Tsun Ki Jerrick ; Schug, Zach ; Basu, Subhasree ; Wang, Fang ; Ricciotti, Emanuela ; DiRusso, Concetta ; Murphy, Maureen E. ; Vonderheide, Robert H. ; Lieberman, Paul M. ; Mulligan, Charles ; Nam, Brian ; Hockstein, Neil ; Masters, Gregory ; Guarino, Michael ; Lin, Cindy ; Nefedova, Yulia ; Black, Paul ; Kagan, Valerian E. ; Gabrilovich, Dmitry I.</creator><creatorcontrib>Veglia, Filippo ; Tyurin, Vladimir A. ; Blasi, Maria ; De Leo, Alessandra ; Kossenkov, Andrew V. ; Donthireddy, Laxminarasimha ; To, Tsun Ki Jerrick ; Schug, Zach ; Basu, Subhasree ; Wang, Fang ; Ricciotti, Emanuela ; DiRusso, Concetta ; Murphy, Maureen E. ; Vonderheide, Robert H. ; Lieberman, Paul M. ; Mulligan, Charles ; Nam, Brian ; Hockstein, Neil ; Masters, Gregory ; Guarino, Michael ; Lin, Cindy ; Nefedova, Yulia ; Black, Paul ; Kagan, Valerian E. ; Gabrilovich, Dmitry I.</creatorcontrib><description>Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite recent advances in the understanding of PMN-MDSC biology, the mechanisms responsible for the pathological activation of neutrophils are not well defined, and this limits the selective targeting of these cells. Here we report that mouse and human PMN-MDSCs exclusively upregulate fatty acid transport protein 2 (FATP2). Overexpression of FATP2 in PMN-MDSCs was controlled by granulocyte–macrophage colony-stimulating factor, through the activation of the STAT5 transcription factor. Deletion of FATP2 abrogated the suppressive activity of PMN-MDSCs. The main mechanism of FATP2-mediated suppressive activity involved the uptake of arachidonic acid and the synthesis of prostaglandin E 2 . The selective pharmacological inhibition of FATP2 abrogated the activity of PMN-MDSCs and substantially delayed tumour progression. In combination with checkpoint inhibitors, FATP2 inhibition blocked tumour progression in mice. Thus, FATP2 mediates the acquisition of immunosuppressive activity by PMN-MDSCs and represents a target to inhibit the functions of PMN-MDSCs selectively and to improve the efficiency of cancer therapy. The lipid transporter FATP2 reprograms neutrophils to polymorphonuclear myeloid-derived suppressor cells by mediating the uptake of arachidonic acid and promoting the synthesis of prostaglandin E 2 .</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/s41586-019-1118-2</identifier><identifier>PMID: 30996346</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13 ; 13/106 ; 13/31 ; 13/44 ; 42/41 ; 45/91 ; 631/250/580 ; 631/67/327 ; 64/60 ; Aged ; Animals ; Arachidonic acid ; Arachidonic Acid - metabolism ; Bone marrow ; Cancer ; Cancer treatment ; Cell activation ; Clonal deletion ; Colony-stimulating factor ; Dendritic cells ; Dinoprostone - metabolism ; Fatty Acid Transport Proteins - antagonists &amp; inhibitors ; Fatty Acid Transport Proteins - metabolism ; Fatty acids ; Fatty Acids - metabolism ; Female ; Gene expression ; Genomes ; Granulocyte-macrophage colony stimulating factor ; Health aspects ; Humanities and Social Sciences ; Humans ; Immune checkpoint ; Immune response ; Immunosuppressive agents ; Leukocytes (neutrophilic) ; Lipid Metabolism ; Lipids ; Macrophage colony stimulating factor ; Macrophages ; Male ; Medical schools ; Mice ; Middle Aged ; multidisciplinary ; Neoplasms - metabolism ; Neoplasms - pathology ; Neutrophils ; Neutrophils - metabolism ; Neutrophils - pathology ; Pharmacology ; Physiological aspects ; Prostaglandin E2 ; Prostaglandins ; Protein transport ; Proteins ; Science ; Science (multidisciplinary) ; Stat5 protein ; STAT5 Transcription Factor - metabolism ; Suppressor cells ; Transcription activation ; Transport ; Transport proteins ; Triglycerides ; Tumors ; Unsaturated fatty acids</subject><ispartof>Nature (London), 2019-05, Vol.569 (7754), p.73-78</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2019</rights><rights>COPYRIGHT 2019 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group May 2, 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c720t-592c84f846faf17b7fefde5434b5e130097e6b626be5d5ac4eba5e961f3538293</citedby><cites>FETCH-LOGICAL-c720t-592c84f846faf17b7fefde5434b5e130097e6b626be5d5ac4eba5e961f3538293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30996346$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Veglia, Filippo</creatorcontrib><creatorcontrib>Tyurin, Vladimir A.</creatorcontrib><creatorcontrib>Blasi, Maria</creatorcontrib><creatorcontrib>De Leo, Alessandra</creatorcontrib><creatorcontrib>Kossenkov, Andrew V.</creatorcontrib><creatorcontrib>Donthireddy, Laxminarasimha</creatorcontrib><creatorcontrib>To, Tsun Ki Jerrick</creatorcontrib><creatorcontrib>Schug, Zach</creatorcontrib><creatorcontrib>Basu, Subhasree</creatorcontrib><creatorcontrib>Wang, Fang</creatorcontrib><creatorcontrib>Ricciotti, Emanuela</creatorcontrib><creatorcontrib>DiRusso, Concetta</creatorcontrib><creatorcontrib>Murphy, Maureen E.</creatorcontrib><creatorcontrib>Vonderheide, Robert H.</creatorcontrib><creatorcontrib>Lieberman, Paul M.</creatorcontrib><creatorcontrib>Mulligan, Charles</creatorcontrib><creatorcontrib>Nam, Brian</creatorcontrib><creatorcontrib>Hockstein, Neil</creatorcontrib><creatorcontrib>Masters, Gregory</creatorcontrib><creatorcontrib>Guarino, Michael</creatorcontrib><creatorcontrib>Lin, Cindy</creatorcontrib><creatorcontrib>Nefedova, Yulia</creatorcontrib><creatorcontrib>Black, Paul</creatorcontrib><creatorcontrib>Kagan, Valerian E.</creatorcontrib><creatorcontrib>Gabrilovich, Dmitry I.</creatorcontrib><title>Fatty acid transport protein 2 reprograms neutrophils in cancer</title><title>Nature (London)</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite recent advances in the understanding of PMN-MDSC biology, the mechanisms responsible for the pathological activation of neutrophils are not well defined, and this limits the selective targeting of these cells. Here we report that mouse and human PMN-MDSCs exclusively upregulate fatty acid transport protein 2 (FATP2). Overexpression of FATP2 in PMN-MDSCs was controlled by granulocyte–macrophage colony-stimulating factor, through the activation of the STAT5 transcription factor. Deletion of FATP2 abrogated the suppressive activity of PMN-MDSCs. The main mechanism of FATP2-mediated suppressive activity involved the uptake of arachidonic acid and the synthesis of prostaglandin E 2 . The selective pharmacological inhibition of FATP2 abrogated the activity of PMN-MDSCs and substantially delayed tumour progression. In combination with checkpoint inhibitors, FATP2 inhibition blocked tumour progression in mice. Thus, FATP2 mediates the acquisition of immunosuppressive activity by PMN-MDSCs and represents a target to inhibit the functions of PMN-MDSCs selectively and to improve the efficiency of cancer therapy. The lipid transporter FATP2 reprograms neutrophils to polymorphonuclear myeloid-derived suppressor cells by mediating the uptake of arachidonic acid and promoting the synthesis of prostaglandin E 2 .</description><subject>13</subject><subject>13/106</subject><subject>13/31</subject><subject>13/44</subject><subject>42/41</subject><subject>45/91</subject><subject>631/250/580</subject><subject>631/67/327</subject><subject>64/60</subject><subject>Aged</subject><subject>Animals</subject><subject>Arachidonic acid</subject><subject>Arachidonic Acid - metabolism</subject><subject>Bone marrow</subject><subject>Cancer</subject><subject>Cancer treatment</subject><subject>Cell activation</subject><subject>Clonal deletion</subject><subject>Colony-stimulating factor</subject><subject>Dendritic cells</subject><subject>Dinoprostone - metabolism</subject><subject>Fatty Acid Transport Proteins - antagonists &amp; inhibitors</subject><subject>Fatty Acid Transport Proteins - metabolism</subject><subject>Fatty acids</subject><subject>Fatty Acids - metabolism</subject><subject>Female</subject><subject>Gene expression</subject><subject>Genomes</subject><subject>Granulocyte-macrophage colony stimulating factor</subject><subject>Health aspects</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Immune checkpoint</subject><subject>Immune response</subject><subject>Immunosuppressive agents</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lipid Metabolism</subject><subject>Lipids</subject><subject>Macrophage colony stimulating factor</subject><subject>Macrophages</subject><subject>Male</subject><subject>Medical schools</subject><subject>Mice</subject><subject>Middle Aged</subject><subject>multidisciplinary</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Neutrophils</subject><subject>Neutrophils - metabolism</subject><subject>Neutrophils - pathology</subject><subject>Pharmacology</subject><subject>Physiological aspects</subject><subject>Prostaglandin E2</subject><subject>Prostaglandins</subject><subject>Protein transport</subject><subject>Proteins</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Stat5 protein</subject><subject>STAT5 Transcription Factor - metabolism</subject><subject>Suppressor cells</subject><subject>Transcription activation</subject><subject>Transport</subject><subject>Transport proteins</subject><subject>Triglycerides</subject><subject>Tumors</subject><subject>Unsaturated fatty acids</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10tFq1TAYB_AgijtOH8AbKXo1pDNJkzS983DYdDA20ImXIU2_1IzTtEtS2N5mz-KTmcOZzgNn5CKk-X1fk_aP0FuCjwmu5KfICJeixKQpCSGypM_QgrBalEzI-jlaYExliWUlDtCrGK8xxpzU7CU6qHDTiIqJBfp8qlO6K7RxXZGC9nEaQyqmMCZw_vc9LQLkRR_0EAsPcwrj9MutY-F8YbQ3EF6jF1avI7x5mA_Rj9OTq9XX8vzyy9lqeV6amuJU8oYayaxkwmpL6ra2YDvgrGItB1Jh3NQgWkFFC7zj2jBoNYdGEFvxStKmOkQftn3zcW5miEldj3Pw-ZWKUsoa3FDJH1Wv16Cct2O-lBlcNGrJJSOUy5pmVe5RPXgIej16sC4_3vHv93gzuRv1Pzreg_LoYHBmb9ejnYJsEtymXs8xqrPv33btx6ft8urn6mJXk602YYwxgFVTcIMOd4pgtUmO2iZH5eSoTXLUpubdw_ed2wG6fxV_o5IB3YKYt3wP4fEHPN31D3EmyXQ</recordid><startdate>201905</startdate><enddate>201905</enddate><creator>Veglia, Filippo</creator><creator>Tyurin, Vladimir A.</creator><creator>Blasi, Maria</creator><creator>De Leo, Alessandra</creator><creator>Kossenkov, Andrew V.</creator><creator>Donthireddy, Laxminarasimha</creator><creator>To, Tsun Ki Jerrick</creator><creator>Schug, Zach</creator><creator>Basu, Subhasree</creator><creator>Wang, Fang</creator><creator>Ricciotti, Emanuela</creator><creator>DiRusso, Concetta</creator><creator>Murphy, Maureen E.</creator><creator>Vonderheide, Robert H.</creator><creator>Lieberman, Paul M.</creator><creator>Mulligan, Charles</creator><creator>Nam, Brian</creator><creator>Hockstein, Neil</creator><creator>Masters, Gregory</creator><creator>Guarino, Michael</creator><creator>Lin, Cindy</creator><creator>Nefedova, Yulia</creator><creator>Black, Paul</creator><creator>Kagan, Valerian E.</creator><creator>Gabrilovich, Dmitry I.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ATWCN</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7TG</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>R05</scope><scope>RC3</scope><scope>S0X</scope><scope>SOI</scope></search><sort><creationdate>201905</creationdate><title>Fatty acid transport protein 2 reprograms neutrophils in cancer</title><author>Veglia, Filippo ; Tyurin, Vladimir A. ; Blasi, Maria ; De Leo, Alessandra ; Kossenkov, Andrew V. ; Donthireddy, Laxminarasimha ; To, Tsun Ki Jerrick ; Schug, Zach ; Basu, Subhasree ; Wang, Fang ; Ricciotti, Emanuela ; DiRusso, Concetta ; Murphy, Maureen E. ; Vonderheide, Robert H. ; Lieberman, Paul M. ; Mulligan, Charles ; Nam, Brian ; Hockstein, Neil ; Masters, Gregory ; Guarino, Michael ; Lin, Cindy ; Nefedova, Yulia ; Black, Paul ; Kagan, Valerian E. ; Gabrilovich, Dmitry I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c720t-592c84f846faf17b7fefde5434b5e130097e6b626be5d5ac4eba5e961f3538293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>13</topic><topic>13/106</topic><topic>13/31</topic><topic>13/44</topic><topic>42/41</topic><topic>45/91</topic><topic>631/250/580</topic><topic>631/67/327</topic><topic>64/60</topic><topic>Aged</topic><topic>Animals</topic><topic>Arachidonic acid</topic><topic>Arachidonic Acid - metabolism</topic><topic>Bone marrow</topic><topic>Cancer</topic><topic>Cancer treatment</topic><topic>Cell activation</topic><topic>Clonal deletion</topic><topic>Colony-stimulating factor</topic><topic>Dendritic cells</topic><topic>Dinoprostone - metabolism</topic><topic>Fatty Acid Transport Proteins - antagonists &amp; inhibitors</topic><topic>Fatty Acid Transport Proteins - metabolism</topic><topic>Fatty acids</topic><topic>Fatty Acids - metabolism</topic><topic>Female</topic><topic>Gene expression</topic><topic>Genomes</topic><topic>Granulocyte-macrophage colony stimulating factor</topic><topic>Health aspects</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Immune checkpoint</topic><topic>Immune response</topic><topic>Immunosuppressive agents</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lipid Metabolism</topic><topic>Lipids</topic><topic>Macrophage colony stimulating factor</topic><topic>Macrophages</topic><topic>Male</topic><topic>Medical schools</topic><topic>Mice</topic><topic>Middle Aged</topic><topic>multidisciplinary</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Neutrophils</topic><topic>Neutrophils - metabolism</topic><topic>Neutrophils - pathology</topic><topic>Pharmacology</topic><topic>Physiological aspects</topic><topic>Prostaglandin E2</topic><topic>Prostaglandins</topic><topic>Protein transport</topic><topic>Proteins</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Stat5 protein</topic><topic>STAT5 Transcription Factor - metabolism</topic><topic>Suppressor cells</topic><topic>Transcription activation</topic><topic>Transport</topic><topic>Transport proteins</topic><topic>Triglycerides</topic><topic>Tumors</topic><topic>Unsaturated fatty acids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veglia, Filippo</creatorcontrib><creatorcontrib>Tyurin, Vladimir A.</creatorcontrib><creatorcontrib>Blasi, Maria</creatorcontrib><creatorcontrib>De Leo, Alessandra</creatorcontrib><creatorcontrib>Kossenkov, Andrew V.</creatorcontrib><creatorcontrib>Donthireddy, Laxminarasimha</creatorcontrib><creatorcontrib>To, Tsun Ki Jerrick</creatorcontrib><creatorcontrib>Schug, Zach</creatorcontrib><creatorcontrib>Basu, Subhasree</creatorcontrib><creatorcontrib>Wang, Fang</creatorcontrib><creatorcontrib>Ricciotti, Emanuela</creatorcontrib><creatorcontrib>DiRusso, Concetta</creatorcontrib><creatorcontrib>Murphy, Maureen E.</creatorcontrib><creatorcontrib>Vonderheide, Robert H.</creatorcontrib><creatorcontrib>Lieberman, Paul M.</creatorcontrib><creatorcontrib>Mulligan, Charles</creatorcontrib><creatorcontrib>Nam, Brian</creatorcontrib><creatorcontrib>Hockstein, Neil</creatorcontrib><creatorcontrib>Masters, Gregory</creatorcontrib><creatorcontrib>Guarino, Michael</creatorcontrib><creatorcontrib>Lin, Cindy</creatorcontrib><creatorcontrib>Nefedova, Yulia</creatorcontrib><creatorcontrib>Black, Paul</creatorcontrib><creatorcontrib>Kagan, Valerian E.</creatorcontrib><creatorcontrib>Gabrilovich, Dmitry I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Middle School</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>University of Michigan</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>Environment Abstracts</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veglia, Filippo</au><au>Tyurin, Vladimir A.</au><au>Blasi, Maria</au><au>De Leo, Alessandra</au><au>Kossenkov, Andrew V.</au><au>Donthireddy, Laxminarasimha</au><au>To, Tsun Ki Jerrick</au><au>Schug, Zach</au><au>Basu, Subhasree</au><au>Wang, Fang</au><au>Ricciotti, Emanuela</au><au>DiRusso, Concetta</au><au>Murphy, Maureen E.</au><au>Vonderheide, Robert H.</au><au>Lieberman, Paul M.</au><au>Mulligan, Charles</au><au>Nam, Brian</au><au>Hockstein, Neil</au><au>Masters, Gregory</au><au>Guarino, Michael</au><au>Lin, Cindy</au><au>Nefedova, Yulia</au><au>Black, Paul</au><au>Kagan, Valerian E.</au><au>Gabrilovich, Dmitry I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatty acid transport protein 2 reprograms neutrophils in cancer</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>2019-05</date><risdate>2019</risdate><volume>569</volume><issue>7754</issue><spage>73</spage><epage>78</epage><pages>73-78</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><abstract>Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite recent advances in the understanding of PMN-MDSC biology, the mechanisms responsible for the pathological activation of neutrophils are not well defined, and this limits the selective targeting of these cells. Here we report that mouse and human PMN-MDSCs exclusively upregulate fatty acid transport protein 2 (FATP2). Overexpression of FATP2 in PMN-MDSCs was controlled by granulocyte–macrophage colony-stimulating factor, through the activation of the STAT5 transcription factor. Deletion of FATP2 abrogated the suppressive activity of PMN-MDSCs. The main mechanism of FATP2-mediated suppressive activity involved the uptake of arachidonic acid and the synthesis of prostaglandin E 2 . The selective pharmacological inhibition of FATP2 abrogated the activity of PMN-MDSCs and substantially delayed tumour progression. In combination with checkpoint inhibitors, FATP2 inhibition blocked tumour progression in mice. Thus, FATP2 mediates the acquisition of immunosuppressive activity by PMN-MDSCs and represents a target to inhibit the functions of PMN-MDSCs selectively and to improve the efficiency of cancer therapy. The lipid transporter FATP2 reprograms neutrophils to polymorphonuclear myeloid-derived suppressor cells by mediating the uptake of arachidonic acid and promoting the synthesis of prostaglandin E 2 .</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>30996346</pmid><doi>10.1038/s41586-019-1118-2</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-0836
ispartof Nature (London), 2019-05, Vol.569 (7754), p.73-78
issn 0028-0836
1476-4687
language eng
recordid cdi_proquest_journals_2224909285
source MEDLINE; Nature; Alma/SFX Local Collection
subjects 13
13/106
13/31
13/44
42/41
45/91
631/250/580
631/67/327
64/60
Aged
Animals
Arachidonic acid
Arachidonic Acid - metabolism
Bone marrow
Cancer
Cancer treatment
Cell activation
Clonal deletion
Colony-stimulating factor
Dendritic cells
Dinoprostone - metabolism
Fatty Acid Transport Proteins - antagonists & inhibitors
Fatty Acid Transport Proteins - metabolism
Fatty acids
Fatty Acids - metabolism
Female
Gene expression
Genomes
Granulocyte-macrophage colony stimulating factor
Health aspects
Humanities and Social Sciences
Humans
Immune checkpoint
Immune response
Immunosuppressive agents
Leukocytes (neutrophilic)
Lipid Metabolism
Lipids
Macrophage colony stimulating factor
Macrophages
Male
Medical schools
Mice
Middle Aged
multidisciplinary
Neoplasms - metabolism
Neoplasms - pathology
Neutrophils
Neutrophils - metabolism
Neutrophils - pathology
Pharmacology
Physiological aspects
Prostaglandin E2
Prostaglandins
Protein transport
Proteins
Science
Science (multidisciplinary)
Stat5 protein
STAT5 Transcription Factor - metabolism
Suppressor cells
Transcription activation
Transport
Transport proteins
Triglycerides
Tumors
Unsaturated fatty acids
title Fatty acid transport protein 2 reprograms neutrophils in cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-07T08%3A30%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatty%20acid%20transport%20protein%C2%A02%20reprograms%20neutrophils%20in%20cancer&rft.jtitle=Nature%20(London)&rft.au=Veglia,%20Filippo&rft.date=2019-05&rft.volume=569&rft.issue=7754&rft.spage=73&rft.epage=78&rft.pages=73-78&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/s41586-019-1118-2&rft_dat=%3Cgale_proqu%3EA584125872%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2224909285&rft_id=info:pmid/30996346&rft_galeid=A584125872&rfr_iscdi=true